American Healthcare REIT AHR
NYSE AHR
$58.07 +0.29 (+0.50%)
At close: Nov 16, 2026 · 4:00 PM EST

American Healthcare REIT (AHR) Price to Book (2024 - 2026)

Updated

American Healthcare REIT's Price to Book came in at 2.13 for Q3 2026, down 22.0% from 2.73 a year earlier and down 21.5% from the prior quarter.

Analysis

American Healthcare REIT (AHR) Price to Book (2024 - 2026) Analysis & Trends

For FY2025, American Healthcare REIT's Price to Book was 2.60, up 61.6% from FY2024.

  • Going back by year, Price to Book was 1.61 in FY2024.
  • The Q3 2026 figure represents the lowest quarterly Price to Book since Q1 2025.
  • Year-over-year, Price to Book increased in six of the last seven quarters, with growth averaging 61.2%.
  • Business Quant data shows AHR's Price to Book at 2.71 (Q2 2026), 2.54 (Q1 2026) and 2.60 (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Welltower 177.76 Bn 163.79 Bn 1.47 Bn
2 Prologis 120.35 Bn 114.31 Bn -
3 Simon Property 74.99 Bn 72.03 Bn -
4 Public Storage 61.37 Bn 60.10 Bn 112.08 Mn
5 Realty Income 55.33 Bn 53.60 Bn -
6 Ventas 45.69 Bn 44.37 Bn -3.39 Bn
7 Vivmark Residential 37.60 Bn 36.79 Bn -
8 Ryman Hospitality Properties 36.49 Bn 34.88 Bn 266.41 Mn
9 Extra Space Storage 33.35 Bn 32.26 Bn 650.96 Mn
10 American Healthcare REIT 12.58 Bn 11.82 Bn 177.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 2.13
Jun 30, 2026 2.71
Mar 31, 2026 2.54
Dec 31, 2025 2.60
Sep 30, 2025 2.73
Jun 30, 2025 2.51
Mar 31, 2025 2.10
Dec 31, 2024 1.61
Sep 30, 2024 1.77
Jun 30, 2024 0.91
Mar 31, 2024 0.91
API Access

American Healthcare REIT Price to Book API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-book&ticker=AHR&period=max&api_key=YOUR_API_KEY